Moving Forward to the Future: SonoScape at FLAUS 2023
2023-09-25In the heart of Panama City, at the prestigious FLAUS, SonoScape demonstrated its commitment to advancing the future of healthcare.
In the heart of Panama City, at the prestigious FLAUS, SonoScape demonstrated its commitment to advancing the future of healthcare.
Together with us, witness the transformative impact of our pioneering ProPet series, and explore its vision for a healthier future for all creatures.
SonoScape’s exceptional performance at the 31st International EAES Congress 2023 in Rome, Italy, showcased transformative medical devices, including AI-powered diagnostics and minimally invasive surgical imaging systems.
The first six months of 2023, as SonoScape embarked on a whirlwind tour de force, have been bustling with global activity, beginning with the high level of engagement and teamwork across the organization.
Throughout the years, your support has been instrumental as we strived to shape our future in the world of endoscopy. Our accomplishments are a testament to collaborative progress, propelling us towards new heights. Join SonoScape at the ESGE Days 2023 for an engaging and content-rich three-day experience, featuring new evidence of interventional endoscopy, and introductions to the latest additions in our GI portfolio.
A vibrant inter-continental exchange of clinical expertise, and forming a new Silk Road of endoscopy
The introduction of SonoScape EUS does not skimp on developing countries in any ways.
Recently, the vice president of SonoScape, Dr. Feng Naizhang, and his team members collaborated with Intel, seeking optimized performance and scalability of S-Fetus 4.0 in obstetric screening assistance.
Following the long-established ultrasound product line, we are further strengthening our position as a global Animal Health medical device provider.
SonoScape demonstrates strength in the four-day accumulation of wisdom and ingenuity in Düsseldorf, Germany
Founded in 2002, SonoScape has committed itself to "Caring for Life through Innovation" by producing technologically advanced ultrasound, endoscopy, MIS (Minimally Invasive Surgery), and IVUS (Intravascular Ultrasound) solutions. SonoScape's extensive installation base provides worldwide sales and service in more than 130 countries, benefiting global healthcare providers with comprehensive imaging diagnostic evidence and seamless technical support. 20% of our total annual revenue is dedicated and invested into R&D, supporting the establishment of 7 global R&D centers spread across the globe. SonoScape strives to continue the creation and delivery of revolutionary healthcare solutions that are designed to shape the future landscape of medical technology.
Copyright © SonoScape Medical Corp. All Rights Reserved. 粤ICP备20054866